Genotoxicity profile of erinacine A-enriched Hericium erinaceus mycelium

Toxicology Reports

Volumn 1, Issue , 2014, Pages 1195-1201

  Li, I Chen ^a   Chen, Yen Lien ^c   Chen, Wan Ping ^a   Lee, Li Ya ^a   Tsai, Yueh Ting ^b   Chen, Chin Chu ^a   Chen, Chin Shuh ^c  

^a Grape King Biotechnology Inc   (Taiwan)

^b Super Laboratory Inc   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Erinacine A; Genotoxicity; Hericium erinaceus; Safety assessment

Indexed keywords

CATECHOLAMINE; CHEMICAL COMPOUND; ERINACINE A; NERVE GROWTH FACTOR; UNCLASSIFIED DRUG;

AMES TEST; ARTICLE; ASTROCYTE; CHROMOSOME ABERRATION; GENOTOXICITY; HERICIUM ERINACEUS; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; MYCELIUM; NONHUMAN; RETICULOCYTE; REVERTANT; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 84922698308     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2014.11.009     Document Type: Article

References (36)

1. Schulte-Herbruggen O., Braun A., Rochlitzer S., Jockers-Scherubl M.C., Hellweg R. Neurotrophic factors-a tool for therapeutic strategies in neurological neuropsychiatric and neuroimmunological diseases?. Curr. Med. Chem. 2007, 14(22):2318-2329.
2. Schulte-Herbruggen O., Jockers-Scherubl M.C., Hellweg R. Neurotrophins: from pathophysiology to treatment in Alzheimer's disease. Curr. Alzheimer Res. 2008, 5(1):38-44.
3. Capsoni S., Ugolini G., Comparini A., Ruberti F., Berardi N., Cattaneo A. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(12):6826-6831.
4. Capsoni S., Giannotta S., Cattaneo A. Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(19):12432-12437.
5. Xu J., Lacoske M.H., Theodorakis E.A. Neurotrophic natural products: chemistry and biology. Angew. Chem. Int. Ed. Engl. 2014, 53(4):956-987.
6. Li G., Yu K., Li F., Xu K., Li J., He S., Cao S., Tan G. Anticancer potential of Hericium erinaceus extracts against human gastrointestinal cancers. J. Ethnopharmacol. 2014, 153(2):521-530.
7. Abdulla M.A., Fard A.A., Sabaratnam V., Wong K.H., Kuppusamy U.R., Abdullah N., Ismail S. Potential activity of aqueous extract of culinary-medicinal Lion's Mane mushroom, Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetideae) in accelerating wound healing in rats. Int. J. Med. Mushrooms 2011, 13(1):33-39.
8. Hiwatashi K., Kosaka Y., Suzuki N., Hata K., Mukaiyama T., Sakamoto K., Shirakawa H., Komai M. Yamabushitake mushroom (Hericium erinaceus) improved lipid metabolism in mice fed a high-fat diet. Biosci. Biotechnol. Biochem. 2010, 74(7):1447-1451.
9. Kim S.P., Kang M.Y., Kim J.H., Nam S.H., Friedman M. Composition and mechanism of antitumor effects of Hericium erinaceus mushroom extracts in tumor-bearing mice. J. Agric. Food Chem. 2011, 59(18):9861-9869.
10. Kim S.P., Moon E., Nam S.H., Friedman M. Hericium erinaceus mushroom extracts protect infected mice against Salmonella Typhimurium-Induced liver damage and mortality by stimulation of innate immune cells. J. Agric. Food Chem. 2012, 60(22):5590-5596.
11. Kim S.P., Nam S.H., Friedman M. Correction to Hericium erinaceus (Lion's Mane) mushroom extracts inhibit metastasis of cancer cells to the lung in CT-26 colon cancer-transplanted mice. J. Agric. Food Chem. 2014, 62(2):528.
12. Kim Y.O., Lee S.W., Oh C.H., Rhee Y.H. Hericium erinaceus suppresses LPS-induced pro-inflammation gene activation in RAW264.7 macrophages. Immunopharmacol. Immunotoxicol. 2012, 34(3):504-512.
13. Shang X., Tan Q., Liu R., Yu K., Li P., Zhao G.P. In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the Lion's Mane mushroom, Hericium erinaceus (higher Basidiomycetes). Int. J. Med. Mushrooms 2013, 15(2):165-174.
14. Wong J.-Y., Abdulla M.A., Raman J., Phan C.-W., Kuppusamy U.R., Golbabapour S., Sabaratnam V. Gastroprotective effects of Lion's Mane mushroom Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetideae) extract against ethanol-induced ulcer in rats. Evid. Based Complement. Alternat. Med. 2013, 2013:9.
15. Wong K.H., Naidu M., David P., Abdulla M.A., Abdullah N., Kuppusamy U.R., Sabaratnam V. Peripheral nerve regeneration following crush injury to rat peroneal nerve by aqueous extract of medicinal mushroom Hericium erinaceus (Bull.: Fr) Pers. (Aphyllophoromycetideae). Evid. Based Complement. Alternat. Med. 2011, 2011:10.
16. Zhang Z., Lv G., Pan H., Pandey A., He W., Fan L. Antioxidant and hepatoprotective potential of endo-polysaccharides from Hericium erinaceus grown on tofu whey. Int. J. Biol. Macromol. 2012, 51(5):1140-1146.
17. Kawagishi H., Ando M., Sakamoto H., Yoshida S., Ojima F., Ishiguro Y., Ukai N., Furukawa S. Hericenones C, D and E, stimulators of nerve growth factor (NGF)-synthesis, from the mushroom Hericium erinaceum. Tetrahedron Lett. 1991, 32(35):4561-4564.
18. Kawagishi H., Ando M., Shinba K., Sakamoto H., Yoshida S., Ojima F., Ishiguro Y., Ukai N., Furukawa S. Chromans, hericenones F, G and H from the mushroom Hericium erinaceum. Phytochemistry 1992, 32(1):175-178.
19. Kawagishi H., Shimada A., Hosokawa S., Mori H., Sakamoto H., Ishiguro Y., Sakemi S., Bordner J., Kojima N., Furukawa S. Erinacines E, F, and G, stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett. 1996, 37(41):7399-7402.
20. Kawagishi H., Shimada A., Shirai R., Okamoto K., Ojima F., Sakamoto H., Ishiguro Y., Furukawa S. Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett. 1994, 35(10):1569-1572.
21. Kawagishi H., Simada A., Shizuki K., Ojima F., Mori H., Okamoto K., Sakamoto H., Furukawa S. Erinacine D, a stimulator of NGF-synthesis, from the mycelia of Hericium erinaceum. Heterocycl. Commun. 1996, 2(1):51.
22. Lee E.W., Shizuki K., Hosokawa S., Suzuki M., Suganuma H., Inakuma T., Li J., Ohnishi-Kameyama M., Nagata T., Furukawa S., Kawagish H. Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci. Biotechnol. Biochem. 2000, 64(11):2402-2405.
23. Shimbo M., Kawagishi H., Yokogoshi H. Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats. Nutr. Res. 2005, 25(6):617-623.
24. Mori K., Inatomi S., Ouchi K., Azumi Y., Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother. Res. 2009, 23(3):367-372.
25. Prince M., Prina M., Guerchet M. World Alzheimer Report 2013 2013, Alzheimer's Disease International.
26. Li I.C., Chen Y.L., Lee L.Y., Chen W.P., Tsai Y.T., Chen C.C., Chen C.S. Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceus in a 28-day oral feeding study in Sprague-Dawley rats. Food Chem. Toxicol. 2014, 70(0):61-67.
27. International A. Official Methods of Analysis of AOAC International 1995, AOAC International, Gaithersburg, MD.
28. OECD Test No. 471: Bacterial Reverse Mutation Test 1997, OECD Publishing.
29. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113(3-4):173-215.
30. OECD Test No. 473: In vitro Mammalian Chromosome Aberration Test 1997, OECD Publishing.
31. OECD Test No. 474: Mammalian Erythrocyte Micronucleus Test 1997, OECD Publishing.
32. McCann J., Choi E., Yamasaki E., Ames B.N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. U.S.A. 1975, 72(12):5135-5139.
33. Mortelmans K., Zeiger E. The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 2000, 455(1-2):29-60.
34. Ohuchida A., Yoshida R. Mutagenicity test of cefodizime sodium. J. Toxicol. Sci. 1988, 13(1):245-256.
35. Ishidate M. A proposed battery of tests for the initial evaluation of the mutagenic potential of medicinal and industrial chemicals. Mutat. Res. 1988, 205(1-4):397-407.
36. Daniel D., Crawford J. Myelotoxicity from chemotherapy. Semin. Oncol. 2006, 33(1):74-85.